DongKook Pharmaceutical Co., Ltd.

Informe acción KOSDAQ:A086450

Capitalización de mercado: ₩751.4b

Salud financiera de hoja de balance de DongKook Pharmaceutical

Salud financiera controles de criterios 6/6

DongKook Pharmaceutical tiene un patrimonio de accionistas total de ₩657.6B y una deuda total de ₩66.2B, lo que sitúa su ratio deuda-patrimonio en 10.1%. Sus activos y pasivos totales son ₩921.3B y ₩263.7B respectivamente. El BAIT de DongKook Pharmaceutical es de ₩82.9B, por lo que su ratio de cobertura de intereses es de -75.2. Tiene efectivo e inversiones a corto plazo que ascienden a ₩89.6B.

Información clave

10.1%

Ratio deuda-patrimonio

₩66.24b

Deuda

Ratio de cobertura de intereses-75.2x
Efectivo₩89.61b
Patrimonio₩657.59b
Total pasivo₩263.66b
Activos totales₩921.25b

Actualizaciones recientes sobre salud financiera

Recent updates

DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450) Investors Are Less Pessimistic Than Expected

Aug 07
DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450) Investors Are Less Pessimistic Than Expected

These 4 Measures Indicate That DongKook Pharmaceutical (KOSDAQ:086450) Is Using Debt Reasonably Well

May 29
These 4 Measures Indicate That DongKook Pharmaceutical (KOSDAQ:086450) Is Using Debt Reasonably Well

We Think DongKook Pharmaceutical (KOSDAQ:086450) Can Stay On Top Of Its Debt

May 06
We Think DongKook Pharmaceutical (KOSDAQ:086450) Can Stay On Top Of Its Debt

DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450) Vies For A Place In Your Dividend Portfolio: Here's Why

Apr 06
DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450) Vies For A Place In Your Dividend Portfolio: Here's Why

How Much Of DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450) Do Insiders Own?

Mar 15
How Much Of DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450) Do Insiders Own?

The DongKook Pharmaceutical (KOSDAQ:086450) Share Price Has Gained 136%, So Why Not Pay It Some Attention?

Feb 28
The DongKook Pharmaceutical (KOSDAQ:086450) Share Price Has Gained 136%, So Why Not Pay It Some Attention?

DongKook Pharmaceutical Co., Ltd.'s (KOSDAQ:086450) Stock Is Going Strong: Is the Market Following Fundamentals?

Feb 14
DongKook Pharmaceutical Co., Ltd.'s (KOSDAQ:086450) Stock Is Going Strong: Is the Market Following Fundamentals?

DongKook Pharmaceutical (KOSDAQ:086450) Seems To Use Debt Quite Sensibly

Feb 01
DongKook Pharmaceutical (KOSDAQ:086450) Seems To Use Debt Quite Sensibly

DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450) Shares Could Be 47% Below Their Intrinsic Value Estimate

Jan 19
DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450) Shares Could Be 47% Below Their Intrinsic Value Estimate

The Attractive Combination That Could Earn DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450) A Place In Your Dividend Portfolio

Jan 06
The Attractive Combination That Could Earn DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450) A Place In Your Dividend Portfolio

DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450) Looks Like A Good Stock, And It's Going Ex-Dividend Soon

Dec 24
DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450) Looks Like A Good Stock, And It's Going Ex-Dividend Soon

With EPS Growth And More, DongKook Pharmaceutical (KOSDAQ:086450) Is Interesting

Dec 21
With EPS Growth And More, DongKook Pharmaceutical (KOSDAQ:086450) Is Interesting

What Kind Of Investors Own Most Of DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450)?

Dec 08
What Kind Of Investors Own Most Of DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450)?

The DongKook Pharmaceutical (KOSDAQ:086450) Share Price Is Up 177% And Shareholders Are Boasting About It

Nov 23
The DongKook Pharmaceutical (KOSDAQ:086450) Share Price Is Up 177% And Shareholders Are Boasting About It

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo (₩481.2B) de A086450 superan a sus pasivos a corto plazo (₩225.4B).

Pasivo a largo plazo: Los activos a corto plazo de A086450 (₩481.2B) superan a sus pasivos a largo plazo (₩38.2B).


Historial y análisis de deuda-patrimonio

Nivel de deuda: A086450 tiene más efectivo que su deuda total.

Reducción de la deuda: El ratio deuda-patrimonio de A086450 ha pasado de 18.5% a 10.1% en los últimos 5 años.

Cobertura de la deuda: La deuda de A086450 está bien cubierta por el flujo de caja operativo (86.2%).

Cobertura de intereses: A086450 gana más intereses de los que paga, por lo que la cobertura de pagos de intereses no es preocupante.


Hoja de balance


Descubre empresas con salud financiera